維生素D檢測市場－2026-2031年預測

預計維生素 D 檢測市場將從 2025 年的 948,438,000 美元成長到 2031 年的 1,567,131,000 美元，複合年成長率為 8.73%。

維生素D檢測市場正經歷強勁的需求成長，這主要得益於人們普遍認知到維生素D在骨骼健康、免疫功能以及預防慢性疾病（包括骨質疏鬆症、1型糖尿病和某些惡性腫瘤）方面的重要作用。維生素D缺乏仍然是全球公共衛生面臨的一大挑戰，人們普遍認為維生素D缺乏會增加高血壓、氣喘加重、自體免疫疾病、失智症、憂鬱症和多種癌症的風險。不斷提高的健康意識以及越來越多的證據表明低25-羥基維生素D水平與不良後果相關，持續推動基層醫療、內分泌學和預防醫學領域開展維生素D篩檢。

骨質疏鬆症及相關脆性骨折的日益普遍，尤其是在高齡化社會中，是推動市場發展的關鍵因素。國際骨質疏鬆症基金會報告稱，50歲及以上的女性中，每三人就有一人會經歷骨質疏鬆性骨折；男性中，每五人就有一人會經歷骨質疏鬆性骨折。全球每年約有890萬例與骨質疏鬆症相關的骨折。老年人和身心障礙者由於戶外活動受限，導致久坐的室內生活方式、極端天氣以及日照減少，進一步加劇了骨質疏鬆症的發生率，從而產生了對精準診斷監測的持續需求。

政府和非政府組織所進行的宣傳活動已被證明能有效將潛在的維生素D短缺轉化為可衡量的檢測量。強調增強免疫力和預防慢性病的系統性公共衛生宣傳活動持續推動消費者和醫生主導進行維生素D檢測，尤其是在以往維生素D水平認知度較低的地區。

預計北美將在整個預測期內保持市場領先地位，這主要得益於50歲及以上人群骨質疏鬆症負擔的加重、先進的檢測基礎設施以及積極的標準化舉措。美國疾病管制與預防中心（CDC）的維生素D標準化和認證計畫仍然是檢測可靠性的基礎，確保了分析的準確性和跨平台可比性。高人均醫療保健支出和廣泛的預防性篩檢保險覆蓋進一步鞏固了該地區的市場主導地位。

由於25-羥基維生素D半衰期長、穩定性好，且與全身蘊藏量具有明確的相關性，因此其檢測在臨床實務中仍佔據主導地位。骨化三醇（1,25-二羥基維生素D）檢測在某些腎臟和副甲狀腺疾病中仍具有一定的效用，但在常規檢測量中所佔比例仍然很小。

主要診斷試劑生產商憑藉其獲得 FDA 批准和 CDC 認證的平台，保持強大的市場地位。

• 雅培公司推出 Architect 25-OH 維生素 D檢測法，這是一款全自動化學冷光微粒免疫檢測盒，具有高通量功能，適用於醫院和實驗室。
• 西門子醫療銷售的「總維生素 D 檢測」已獲得 CDC 認證，並具有經過驗證的兒童檢驗範圍，可支援對所有年齡層進行準確解讀。

近期產品創新主要集中在降低偵測門檻的去分散式檢查模式。 2023年2月，Hurdle公司推出了Chronomics品牌的實驗室級維生素D家用檢測套組，消費者可在家中自行採集檢體，並由集中式實驗室進行分析。此類產品順應了遠距遠端醫療和預防保健的趨勢，推動了檢測方式從傳統的血液採集場所擴展到更廣泛的領域。

整體而言，維生素D檢測產業正受益於流行病學、行為學和技術等多方面因素的協同作用。維生素D缺乏症的持續流行、人口老化、室內生活方式的轉變以及面向消費者的直接服務的不斷擴展，共同推動了市場的持續成長。預計北美將繼續在檢測量和分析標準化方面主導，而25-羥基維生素D仍然是公認的黃金標準指標。公共衛生領域持續關注最佳化免疫功能和預防骨折，這必將使已開發經濟體和新興經濟體的醫療保健系統對可靠且便捷的維生素D狀態評估的需求保持在高位。

本報告的主要優勢：

• 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
• 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
• 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
• 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
• 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

• 歷史資料（2021-2025 年）和預測資料（2026-2031 年）
• 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
• 競爭對手定位、策略和市場佔有率分析
• 按業務板塊和地區（國家）分類的收入成長和預測分析
• 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

• 市場概覽
• 市場定義
• 分析範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策和法規
• 策略建議

第4章 技術展望

第5章 依維生素類型分類的維生素D檢測市場

• 介紹
• 維生素D2
• 維生素D3

6. 依檢測方法分類的維生素D檢測市場

• 介紹
• 25-羥基維生素D檢測
• 1,25-二羥基維生素D檢測

7. 維生素D檢測市場依方法論分類

• 介紹
• 免疫檢測
• 液相層析法/質譜聯用（LC-MS）
• 其他

第8章：維生素D檢測市場應用

• 介紹
• 骨軟化症
• 疳
• 骨質疏鬆症
• 其他

9. 按最終用戶分類的維生素D檢測市場

• 介紹
• 醫院和診所
• 診斷中心
• 其他

第10章 各地區維生素D檢測市場

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第11章 競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 企業合併、協議、商業合作
• 競爭對手儀錶板

第12章：公司簡介

• Abbott
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Quest Diagnostics Incorporated
• BIOMERIEUX
• DiaSorin SpA
• Thermo Fisher Scientific Inc.
• Beckman Coulter, Inc.
• Tosoh Bioscience, Inc.
• Bio-Rad Laboratories, Inc

第13章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 分析方法
• 簡稱

The vitamin D testing market, with a 8.73% CAGR, is expected to grow to USD 1567.131 million in 2031 from USD 948.438 million in 2025.

The vitamin D testing market is experiencing robust demand growth, driven by widespread recognition of vitamin D's critical role in skeletal health, immune function, and prevention of chronic conditions including osteoporosis, type 1 diabetes, and certain malignancies. Hypovitaminosis D remains a global public health challenge, with deficiency implicated in heightened risk of hypertension, asthma exacerbation, autoimmune disorders, dementia, depression, and various cancers. Increasing health consciousness and expanding evidence linking low 25-hydroxyvitamin D levels to adverse outcomes continue to propel screening uptake across primary care, endocrinology, and preventive medicine settings.

Key market catalysts include the escalating prevalence of osteoporosis and related fragility fractures, particularly in aging populations. The International Osteoporosis Foundation reports that one in three women and one in five men over age 50 will sustain an osteoporotic fracture, while approximately 8.9 million osteoporosis-related fractures occur annually worldwide. Reduced sunlight exposure secondary to sedentary indoor lifestyles, extreme weather patterns, and limited outdoor mobility among elderly and disabled individuals further compounds deficiency rates, creating sustained need for accurate diagnostic monitoring.

Awareness initiatives from governmental and non-governmental organizations are proving instrumental in converting latent deficiency into measurable testing volume. Structured public health campaigns emphasizing immune resilience and chronic disease prevention continue to drive consumer and physician-initiated testing, particularly in regions with historically low baseline knowledge of vitamin D status.

North America is poised to retain market leadership throughout the forecast period, supported by elevated osteoporosis burden among individuals aged 50 and older, advanced laboratory infrastructure, and proactive standardization efforts. The CDC Vitamin D Standardization-Certification Program remains a cornerstone for assay reliability, ensuring analytical accuracy and comparability across platforms. High per-capita healthcare expenditure and broad insurance coverage for preventive screening further solidify regional dominance.

The 25-hydroxyvitamin D assay continues to dominate clinical practice due to its long half-life, stability, and established correlation with total body stores. Calcitriol (1,25-dihydroxyvitamin D) testing retains niche utility in specific renal and parathyroid disorders but constitutes a minor share of routine volume.

Major diagnostic manufacturers maintain strong positions through FDA-cleared and CDC-certified platforms:

• Abbott offers the Architect 25-OH Vitamin D assay, a fully automated chemiluminescent microparticle immunoassay delivering high-throughput performance in hospital and reference laboratories.
• Siemens Healthineers markets the Vitamin D Total Assay, notable for CDC certification and pediatric reference interval validation, supporting accurate interpretation across age groups.

Recent product innovation has centered on decentralized testing models that lower access barriers. In February 2023, Hurdle introduced a laboratory-grade vitamin D home testing kit under its Chronomics brand, providing consumers direct-to-home sample collection with centralized laboratory analysis. Such offerings align with broader telehealth and preventive wellness trends, expanding testing beyond traditional phlebotomy settings.

Overall, the vitamin D testing sector benefits from converging epidemiological, behavioral, and technological tailwinds. Persistent deficiency prevalence, aging demographics, indoor lifestyle shifts, and expanding direct-to-consumer options collectively underpin sustained market expansion. North America will continue to lead in both testing volume and analytical standardization, while 25-hydroxyvitamin D remains the unequivocal gold-standard marker. Ongoing public health emphasis on immune optimization and fracture prevention ensures that demand for reliable, accessible vitamin D status assessment will remain elevated across developed and emerging healthcare systems alike.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Global Vitamin D Testing Market is analyzed into the following segments:

• By Vitamin Type
• Vitamin D2
• Vitamin D3
• By Test Type
• 25-Hydroxyvitamin D Testing
• 1,25-Dihydroxyvitamin D Testing
• By Method
• Immunoassay
• Liquid Chromatography/Mass Spectroscopy (LC-MS)
• Others
• By Application
• Osteomalacia
• Rickets
• Osteoporosis
• Others
• By End-User
• Hospitals & Clinics
• Diagnostics Centers
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. VITAMIN D TESTING MARKET BY VITAMIN TYPE

• 5.1. Introduction
• 5.2. Vitamin D2
• 5.3. Vitamin D3

6. VITAMIN D TESTING MARKET BY TEST TYPE

• 6.1. Introduction
• 6.2. 25-Hydroxyvitamin D Testing
• 6.3. 1,25-Dihydroxyvitamin D Testing

7. VITAMIN D TESTING MARKET BY METHOD

• 7.1. Introduction
• 7.2. Immunoassay
• 7.3. Liquid Chromatography/ Mass Spectroscopy (LC-MS)
• 7.4. Others

8. VITAMIN D TESTING MARKET BY APPLICATION

• 8.1. Introduction
• 8.2. Osteomalacia
• 8.3. Rickets
• 8.4. Osteoporosis
• 8.5. Others

9. VITAMIN D TESTING MARKET BY END-USER

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Diagnostics Centers
• 9.4. Others

10. VITAMIN D TESTING MARKET BY GEOGRAPHY

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. USA
  • 10.2.2. Canada
  • 10.2.3. Mexico
• 10.3. South America
  • 10.3.1. Brazil
  • 10.3.2. Argentina
  • 10.3.3. Others
• 10.4. Europe
  • 10.4.1. Germany
  • 10.4.2. France
  • 10.4.3. United Kingdom
  • 10.4.4. Spain
  • 10.4.5. Others
• 10.5. Middle East and Africa
  • 10.5.1. Saudi Arabia
  • 10.5.2. UAE
  • 10.5.3. Israel
  • 10.5.4. Others
• 10.6. Asia Pacific
  • 10.6.1. China
  • 10.6.2. India
  • 10.6.3. Japan
  • 10.6.4. South Korea
  • 10.6.5. Indonesia
  • 10.6.6. Thailand
  • 10.6.7. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 11.1. Major Players and Strategy Analysis
• 11.2. Market Share Analysis
• 11.3. Mergers, Acquisitions, Agreements, and Collaborations
• 11.4. Competitive Dashboard

12. COMPANY PROFILES

• 12.1. Abbott
• 12.2. F. Hoffmann-La Roche Ltd
• 12.3. Siemens Healthineers AG
• 12.4. Quest Diagnostics Incorporated
• 12.5. BIOMERIEUX
• 12.6. DiaSorin S.p.A.
• 12.7. Thermo Fisher Scientific Inc.
• 12.8. Beckman Coulter, Inc.
• 12.9. Tosoh Bioscience, Inc.
• 12.10. Bio-Rad Laboratories, Inc

13. APPENDIX

• 13.1. Currency
• 13.2. Assumptions
• 13.3. Base and Forecast Years Timeline
• 13.4. Key Benefits for the Stakeholders
• 13.5. Research Methodology
• 13.6. Abbreviations